<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> is well known as an <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> that can lead to clinical complications such as <z:e sem="disease" ids="C0027051" disease_type="Disease or Syndrome" abbrv="MR|mi|AMI">heart attack</z:e> or <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>C-<z:chebi fb="7" ids="16670">peptide</z:chebi> as a cleavage product of proinsulin is in the last few decades known as an active <z:chebi fb="7" ids="16670">peptide</z:chebi> with a number of different effects on microvascular and macrovascular complications in type 2 diabetic patients </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and early type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> show elevated levels of C-<z:chebi fb="7" ids="16670">peptide</z:chebi> in blood </plain></SENT>
<SENT sid="3" pm="."><plain>Several last findings demonstrated deposition of C-<z:chebi fb="7" ids="16670">peptide</z:chebi> in the vessel wall in ApoE-deficient mice and induction of local <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Besides that, C-<z:chebi fb="7" ids="16670">peptide</z:chebi> has proliferative effects on human mesangial cells </plain></SENT>
<SENT sid="5" pm="."><plain>This review discusses recently published proinflammatory effects of C-<z:chebi fb="7" ids="16670">peptide</z:chebi> in different tissues </plain></SENT>
</text></document>